Mosby's Advanced Pharmacy Technician E-Book: Mosby's Advanced Pharmacy Technician E-Book

Take your career to the next level with Mosby's Advanced Pharmacy Technician: Principles and Practice! Beginning with an exploration of expanding roles for the pharmacy technician, this resource includes coverage of leadership, management, and technical skills to support career progression and preparation for the new Advanced Pharmacy Technician certification credential. Case studies, critical thinking exercises, chapter quizzes, and a sample exam provide ample opportunities for skills assessment. A perfect companion to Mosby's Pharmacy Technician, this text provides you with the knowledge and tools needed to take charge of your career in the fast-paced and exciting field of pharmacy technology!(Mosby's Pharmacy Technician sold seperately.)- Content is based on ASHP and PTCB standards to match the coverage required in advanced-level pharmacy technician programs and support the new CPhT-Adv credential.- Coverage builds upon the Certified Pharmacy Technician skill set with a variety of advanced-level skills, including medication history and reconciliation, error prevention, hazardous medications, controlled substances, technology considerations, inventory, billing and reimbursement, and management and leadership topics to help students develop a supervisory skill set.- Study and practice opportunities throughout include review questions at the end of each chapter, an exam-review appendix with sample questions, and review questions on the companion Evolve website.- Chapter case studies and critical thinking exercises throughout emphasize real-world problem solving.- Tech Notes and Tech Alerts offer practical tips for on-the-job accuracy and efficiency.

About the Author

Dr. Karen D. Davis is a Professor in the Department of Surgery and the Institute of Medical Science at the University of Toronto, and Head of the Division of Brain, Imaging and Behaviour – Systems Neuroscience at the Krembil Brain Institute; University Health Network. She obtained her PhD in Physiology from the University of Toronto and did a post-doctoral fellowship at John Hopkins University. Dr. Davis is founding member of the University of Toronto Centre for the Study of Pain and currently sits on its Executive Committee. Dr. Davis's early work involved single cell electrophysiology, with discoveries of brain neurons that encode vascular headaches, "silent nociceptors capable of chemical and injury-induced sensitization, and human cortical neurons encoding pain and attention. Over the last 30 years, Dr. Davis has pioneered electrophysiological and brain imaging approaches to investigate mechanisms underlying acute and chronic pain and pain-attention interactions. More recently, she has focused on outcomes of traumatic injuries, plasticity associated with treatment and recovery, and individual factors that contribute to disease vulnerability, recovery, and treatment outcomes. Dr. Davis has given over 175 invited lectures and her work has culminated in 200+ papers and book chapters, with over 16,000 citations and an H-index of 66. She also created a TED-Ed video "How does your brain respond to pain? viewed over 1.6 million times. Dr. Davis has been a Councillor of the International Association for the Study of Pain, is active in neuroethics, research ethics, created a graduate student oath (published in Science), and chaired the IASP presidential task force on the use brain imaging to diagnosis pain, with recommendations published in Nature Reviews Neurology. Dr. Davis has served on the CIHR Advisory Board for the Institute of Neuroscience, Mental Health and Addiction, and has been section editor for the international journal Pain and PainReports. She was a Mayday Pain and Society Fellow and currently sits on their advisory board. Dr. Davis has been inducted into the Johns Hopkins Society of Scholars, the Canadian Academy of Health Sciences, and has received research and mentorship awards. She is currently President-Elect of the Canadian Pain Society and will serve as its president from 2020-22.